Skip to content

Clinical trials

Cardiotoxicity trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20081
20091
20101
20111
20131
20142
20162
20181
20191
20202
20211
20221
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status7
Recruiting4
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group4
AHS Cancer Control Alberta3
University Health Network, Toronto3
Ottawa Hospital Research Institute2
University of Alberta2
Dinesh Thavendiranathan1
Mayo Clinic1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Nova Scotia Health Authority1
St. Boniface Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity24
Breast Neoplasms10
Heart Failure8
Neoplasms7
Lymphoma2
Carcinoma, Renal Cell1
Cardiovascular Diseases1
Hypertension1
Neoplasm Metastasis1
Radiation Injuries1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.